Table 2.
A summary of notable works on risk assessment during the COVID-19 pandemic.
| Research | Application | Methodology | Performance |
|---|---|---|---|
| [73] | COVID-19 diagnosis from symptoms | Fuzzy Inference System | No metrics provided |
| [74] | Vulnerability assessment of individuals | Logistic regression, Gradient Boosted Trees and Closedloop platform | No metrics provided |
| [80] | Mortality risk assessment from COVID-19 | Artificial Neural Network | Accuracy: 86.25%, Sensitivity: 87.50%, Specificity: 85.94%, AUROC: 90.12% |
| [82] | COVID-19 mortality risk assessment using blood samples | Ensemble learning using deep neural network and random forest | Sensitivity 100%, Specificity 91% and Accuracy 92% |
| [84] | COVID-19 recovery period estimation and identification of high risk age groups | Decision tree, Support Vector Machine, Naive Bayes, Logistic Regression, Random Forest and K-nearest Neighbour | Accuracy 99.85% |
| [79] | COVID-19 severity assessment from chest x-ray images | Transfer learning with VGG16 | 0.90 and mean absolute error of 8.5% |
| [85] | Identification of high risk individuals that require hospitalisation and low risk individuals that can recover at home using a chatbot | AI chatbot | No metrics provided |
| [86] | Predict development of acute respiratory distress syndrome (ARDS) of COVID-19 patients from clinical data | Logistic Regression, KNN, Decision Tree, Random Forests and Support Vector Machine | Accuracy: 70% to 80% |